CompletedNot applicableNCT06978010

Efficacy of Platelet-rich Plasma in Improving Postoperative Scarring After Cesarean Delivery

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Saint Andrew Hospital Constanta
Principal Investigator
Vlad Iustin Tica, Proffesor
Ovidius University
Intervention
Platelet-Rich Plasma (PRP) intraoperatively(other)
Enrollment
100 target
Eligibility
18-45 years · FEMALE
Timeline
20232024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06978010 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials